Shares of Neurocrine Biosciences (NBIX) slipped on Wednesday after safety concerns linked to Vykat XR, a rare disease therapy the company added with its acquisition of Soleno Therapeutics this year, ...
SAN DIEGO, July 23, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results